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Prospective Comparison of the Minnesota Multiphasic Personality
Inventory-2 (MMPI-2) and MMPI-2-Restructured Form (MMPI-2-RF)
in Predicting Treatment Outcomes Among Patients with Chronic Low
Back Pain
Anthony M. Tarescavage1 · Judith Scheman2 · Yossef S. Ben‑Porath3

Abstract
The purpose of the current study was to examine the relative utility of the most updated MMPI adult instrument, the Minnesota Multiphasic Personality Inventory-2-Restructured Form (MMPI-2-RF), which was designed to address
psychometric limitations of the MMPI-2. To this end, we compared mean scores and correlates of emotional distress
treatment outcomes using the Depression Anxiety Stress Scales in a sample of 230 patients (73 males, 157 females) who
had completed an inter-disciplinary chronic pain rehabilitation program. Structural equation modeling analyses indicated
that higher scale scores from all the MMPI-2-RF substantive domains were meaningfully associated with worse emotional
distress outcomes, whereas the MMPI-2 Clinical Scales generally did not have any meaningful associations. Similar
results were found in additional analyses using a clinically significant change framework with more direct clinical
implications. The results of this study provide preliminary support for the use of the MMPI-2-RF among patients with
chronic low back pain.
Keywords MMPI-2-RF · Chronic pain · Back pain · Treatment outcome · Applied assessment

Introduction
Chronic low back pain has a considerable impact on society.
The prevalence of the disorder is rising (Freburger et al.,
2009; Rubin, 2007), which is a prominent cause of disability
(McNeil & Binette, 2001) and sick days (LaBar, 1992), and
it has substantial economic influence (Guo, Tanaka, Halperin, & Cameron, 1999; Katz, 2006). Moreover, it is associated with psychological problems, as the 12-month prevalence rates of mood and anxiety disorders in this population
are 17.5 and 26.5% (Von Korff et al., 2005), respectively,
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which are nearly double the general population prevalence
rates (Kessler et al., 2004). Chronic pain is also associated
with the increased rates of illicit drug use, particularly opioid abuse (Manchikanti et al., 2006).
According to the biopsychosocial perspective of pain
(Gatchel, McGeary, McGeary, & Lippe, 2014; Gatchel,
Peng, Peters, Fuchs, & Turk, 2007), biological, psychological, and social factors interact to influence the experience of
pain. Gatchel et al. (2007) provide an overview of how these
factors affect the perception of illness, noting that pertinent
psychological factors include mood problems, such as anxiety and depression, as well as cognitions that may lead to
pain catastrophizing. The American College of Physicians
and the American Pain Society recommend interdisciplinary
treatment with an assessment of these and other psychosocial factors (Chou et al., 2007). They have been found to be
stronger predictors of outcome than physical examinations,
severity of pain, and duration of pain (Chou et al., 2007).
Psychological testing is one way to assess for these factors, with the Minnesota Multiphasic Personality Inventory (MMPI) (Hathaway & McKinley, 1943) and MMPI-2
(Butcher et al., 2001) historically having been the most

frequently used psychological tests among chronic pain
patients (Piotrowski, 1998; Piotrowski & Lubin, 1990).
However, use of these instruments began to decline in
chronic pain settings in the mid-to-late-1990s. During this
time, a series of articles debating the utility of the instrument
were published in Pain Forum. Main and Spanswick (1995)
began the debate with an article entitled “Personality Assessment and the Minnesota Multiphasic Personality Inventory:
50 years on: Do we still need our security blanket?” The
authors criticized the test for its psychometric shortcomings,
writing, “Its inherent structural weaknesses undermine its
clinical validity, even when it does provide additional clinical information” (p. 92). They called for prospective chronic
pain outcome studies using advanced quantitative analyses
such as structural equation modeling and measures “which
reflect the world of pain rather than promulgate the sort of
psychoarcheology represented by the MMPI and MMPI-2”
(p. 95). Most of these concerns were echoed by other authors
in the debate (Keefe, Lefebvre, & Beaupre, 1995; Turk &
Fernandez, 1995). However, Bradley (1995) countered these
claims by reviewing a series of research studies indicating
that individuals can be reliably categorized into MMPI Scale
score subgroups, which demonstrate concurrent associations
with factors that may predict outcome (such as pain intensity, medication use, disability, and work status). Overall,
most of the authors in the series agreed that significant
problems with the test’s Clinical Scales (which were nearly
identical to the MMPI’s Clinical Scales) limited the test’s
utility in this setting.
Several years after the debate, the MMPI-2-Restructured
Form (MMPI-2-RF; Ben-Porath & Tellegen, 2008/2011),
was released as an updated version of the MMPI-2. The
MMPI-2-RF is a 338-item broadband measure of psychopathology with 51 scales. The nine Validity Scales of
the test are designed to assess for problematic test-taking
approaches, which include random and acquiescent responding, as well as over- and underreporting of psychological
problems. The test’s substantive scales measure psychological constructs and are anchored by the nine Restructured
Clinical (RC) Scales. The primary goal of the RC Scales
project was to address the psychometric limitations of the
Clinical Scales by substantially reducing the scale overlap
and heterogeneity that complicated their interpretation and
use in research, while still measuring the major distinctive
core constructs assessed by each scale. The constructs measured by the scales were also more clearly tied to modern
psychopathology models and constructs (Sellbom, BenPorath, & Bagby, 2008). These revisions address some of
the primary concerns with the Clinical Scales advanced by
authors in the debate.
The MMPI-2-RF test authors used similar modern scale
development strategies for two substantive scale sets that
complement the RC Scales: (1) the three Higher-Order

Scales that measure internalizing dysfunction, thought dysfunction, and externalizing dysfunction, broadly defined,
and; (2) the 23 Specific Problems Scales that measure RC
Scale subdomains or other, more narrowly focused constructs that are related to, but distinct from those measured
by the RC Scales. Revised and improved versions of the
MMPI-2 PSY-5 Scales, which measure broad domains of
abnormal personality, are also included on the test. Overall, the MMPI-2-RF measures five substantive domains of
personality and psychopathology: (1) Emotional Dysfunction; (2) Thought Dysfunction; (3) Behavioral/Externalizing
Dysfunction; (4) Somatic/Cognitive Problems; and (5) Interpersonal Functioning (see Table 1 for scale descriptions).
McCord and Drerup (2011) demonstrated the improved
interpretive utility of the RC Scales in comparison to the
Clinical Scales in a chronic pain sample. These authors categorized 316 chronic pain patients into depressed and nondepressed diagnostic groups. The depression group included
individuals diagnosed with major depression, dysthymia,
and adjustment disorder, whereas the nondepressed group
was not diagnosed with any form of mood disturbance. They
compared mean scores on the Clinical and RC Scales across
the two groups. In the nondepressed group, mean Clinical
Scale elevations (i.e., scores ≥ 65T) were found on scales
1 (Hypochondriasis), 2 (Depression), 3 (Hysteria), and 8
(Schizophrenia), whereas only RC1 (Somatic Complaints)
produced a mean RC Scale elevation. In the depressed
group, mean clinical elevations were observed for the following Clinical Scales: 1 (Hypochondriasis), 2 (Depression),
3 (Hysteria), 4 (Psychopathic Deviate), 6 (Paranoia), 7 (Psychastenia), and 8 (Schizophrenia). The pattern of elevations
was consistent with the neurotic-triad cluster and code type
typically found in Clinical Scale research in this setting, with
prominent elevations on scales 1, 2, and 3. In stark contrast
to the Clinical Scale findings, mean RC scale elevations were
observed in the depressed group for only RCd (Demoralization), RC1 (Somatic Complaints), and RC2 (Low Positive
Emotions), demonstrating substantially improved discriminant validity. McCord and Drerup (2011) summarize the
implications of the findings from the depressed group:
“The clinician relying on the Clinical Scales would see
clinical-range elevations on all scales except Scale 9, with
extreme elevations on Scales 1, 2, and 3 and troubling elevations on 7 and 8 as well. In contrast, the RC Scales indicate
three things: (a) a significant level of demoralization; (b)
significant somatic complaints; and (c) depression. The latter
set of data is far more consistent with the clinical diagnoses
in the patient charts” (p. 145).

Current Study
Despite the substantial psychometric and interpretive
improvements compared to the Clinical Scales, no study has
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Table 1  Minnesota Multiphasic Personality Inventory-2-Restructured Form Scales
Validity Scales
Inconsistent responding
VRIN-r
TRIN-r
Overreporting
F-r
Fp-r
FS
FBS-r
RBS
Underreporting
L-r
K-r
Higher-Order (H-O) Scales
EID
THD
BXD
Restructured Clinical (RC) Scales
RCd
RC1
RC2
RC3
RC4
RC6
RC7
RC8
RC9
Specific Problem (SP) Scales
Somatic/Cognitive Scales
MLS
GIC
HPC
NUC
COG
Internalizing Scales
SUI
HLP
SFD
NFC
STW
AXY
ANP
BRF
MSF
Externalizing Scales
JCP
SUB
AGG
ACT

Variable response inconsistency-random responding
True response inconsistency-fixed responding
Infrequent responses—responses infrequent in the general population
Infrequent psychopathology responses—responses infrequent in psychiatric populations
Infrequent somatic responses—somatic complaints infrequent in medical patient populations
Symptom validity—somatic and cognitive complaints associated at high levels with overreporting
Response bias scale—exaggerated memory complaints
Uncommon virtues—rarely claimed moral attributes or activities
Adjustment validity—avowals of good psychological adjustment associated at high levels with underreporting
Emotional/internalizing dysfunction—problems associated with mood and affect
Thought dysfunction—problems associated with disordered thinking
Behavioral/externalizing dysfunction—problems associated with under-controlled behavior
Demoralization—general unhappiness and dissatisfaction
Somatic complaints—diffuse physical health complaints
Low positive emotions—lack of positive emotional responsiveness
Cynicism—non-self-referential beliefs expressing distrust and a generally low opinion of others
Antisocial behavior—rule breaking and irresponsible behavior
Ideas of persecution—self-referential beliefs that others pose a threat
Dysfunctional negative emotions—maladaptive anxiety, anger, and irritability
Aberrant experiences—unusual perceptions or thoughts
Hypomanic activation—overactivation, aggression, impulsivity, and grandiosity

Malaise—overall sense of physical debilitation, poor health
Gastrointestinal complaints—nausea, recurring upset stomach, and poor appetite
Head pain complaints—head and neck pain
Neurological complaints—dizziness, weakness, paralysis, loss of balance, etc
Cognitive complaints—memory problems, difficulties concentrating
Suicidal/death ideation—direct reports of suicidal ideation and recent suicide attempts
Helplessness/hopelessness—belief that goals cannot be reached or problems solved
Self-doubt—lack of confidence, feelings of uselessness
Inefficacy—belief that one is indecisive and inefficacious
Stress/worry—preoccupation with disappointments, difficulty with time pressure
Anxiety—pervasive anxiety, frights, frequent nightmares
Anger proneness—becoming easily angered, impatient with others
Behavior-restricting fears—fears that significantly inhibit normal activities
Multiple specific fears—fears of blood, fire, thunder, etc
Juvenile conduct problems—difficulties at school and at home, stealing
Substance abuse—current and past misuse of alcohol and drugs
Aggression—physically aggressive, violent behavior
Activation—heightened excitation and energy level

Table 1  (continued)
Interpersonal Scales
FML

Family problems—conflictual family relationships
IPP
Interpersonal passivity—being unassertive and submissive
SAV
Social avoidance—avoiding or not enjoying social events
SHY
Shyness—bashful, prone to feel inhibited and anxious around others
DSF
Disaffiliativeness—disliking people and being around them
Interest Scales
AES
Aesthetic-literary interests—literature, music, the theater
MEC
Mechanical–physical interests—fixing and building things, the outdoors, sports
Personality Psychopathology Five (PSY-5) Scales
AGGR-r
Aggressiveness-revised—instrumental, goal directed aggression
PSYC-r
Psychoticism-revised—disconnection from reality
DISC-r
Disconstraint-revised—under-controlled behavior
NEGE-r
Negative emotionality/neuroticism-revised—anxiety, insecurity, worry, and fear
INTR-r
Introversion/low positive emotionality-revised—social disengagement and anhedonia
From MMPI-2-RF Manual for Administration, Scoring, and Interpretation by Yossef S. BenPorath and Auke Tellegen. Copyright© 2008, 2011
by the Regents of the University of Minnesota. Reproduced by permission of the University of Minnesota Press. All rights reserved. “Minnesota
Multiphasic Personality Inventory-2-RF®” and “MMPI-2-RF®” are trademarks owned by the Regents of the University of Minnesota

investigated use of the RC Scales to predict outcomes among
chronic pain patients undergoing conventional conservative
treatments. The purpose of the current study was to investigate the ability of the MMPI-2-RF to predict self-reported
emotional distress outcomes among patients with chronic
low back pain completing short-term interdisciplinary rehabilitation treatment. Because this is the first comprehensive
investigation of the revised inventory, rather than test-specific hypotheses, in the context of discovery (Reichenbach,
1938), we investigated the association between all MMPI2-RF scale scores with emotional distress outcomes (as
measured by the Depression Anxiety Stress Scales) (Lovibond & Lovibond, 1995) after controlling for age and gender, as well as pain intensity and duration of pain. In line
with suggestions by Main and Spanswick (1995), we examined these associations using structural equation modeling.
Finally, we compared the scores of interpretive utility and
the predictive capacity of the MMPI-2-RF scales and the
MMPI-2 Clinical Scales, and we expected that the MMPI2-RF scales would demonstrate substantially greater interpretive utility and larger effect sizes in predicting outcome
given its structural and theoretical improvements.

administered the MMPI-2 as well as the Depression Anxiety Stress Scales (DASS) at intake. Overall, 249 (89.6%) of
these individuals were eligible for inclusion because they
completed the program and were administered the DASS
at discharge. Completers participated in the program for an
average of 20.6 days (SD = 6.8).
MMPI-2 items were used to calculate MMPI-2-RF scale
scores, which is possible because all 338 MMPI-2-RF
items are included in the MMPI-2 booklet. Past research
has demonstrated the relative comparability of MMPI-2-RF
scale scores generated from both booklets (Tellegen & BenPorath, 2008/2011; Van der Heijden, Egger, & Derksen,
2010). An additional 19 participants were excluded from the
analyses because they produced invalid MMPI-2-RF profiles
according to the test authors’ published guidelines, which
included cannot say, CNS ≥ Raw score 18; variable response
inconsistency, VRIN-r ≥ 80; true response inconsistency,
TRIN-r ≥ 80; infrequent responding, F-r = 120; and infrequent psychopathology responses, Fp-r ≥ 100 (Ben-Porath
& Tellegen, 2008/2011).
The final sample included 230 patients (73 males, 157
females) after exclusions.1 The majority of the sample was
married (62.6%) and other martial statuses included never

Methods
Participants
Participants were drawn from an archival sample of 278 nonconsecutive chronic pain patients (93 males, 185 females)
who presented with lower back pain to a 3–4 week interdisciplinary pain treatment program in Northeast Ohio and were

1
There were a total of 14 additional participants (6% of sample) who
would have been excluded from the study if we removed individuals
with elevated scores (≥ 100T) on Fs, FBS-r, or RBS. According to
Ben-Porath and Tellegen (2008/2011), elevated scores on these three
validity scales suggest scores on the Somatic/Cognitive scales may
be invalid. We ran the study analyses after excluding these 14 individuals, and the interpretation of the findings did not meaningfully
change.
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married (19.6%), divorced (10.0%), widowed (3.0%), and
separated (1.3%). The average age was 46.5 (SD = 14.5)
,and the average years of education was 14.3 (SD = 3.1).
No significant differences were observed on most demographic variables between the excluded individuals and
the final sample (p’s > .23). However, excluded individuals were more likely to have a marital status of separated,
χ2(5) = 11.455, p = .043, Std. residual = 2.6. In the final
sample, the most common DSM-IV-TR (American Psychiatric Association, 2000) diagnoses included major depressive disorder (48.8%), a substance use disorder (36.3%),
an anxiety disorder (18.2%), a bipolar disorder (4.9%),
post-traumatic stress disorder (2.6%), or a somatization
disorder (0.9%)(categories are not mutually exclusive). To
some extent, these rates may underestimate comorbid psychopathology because billing was not based the presence
of a mental disorder. Common comorbid medical conditions included joint pain (44.8%), neck pain (38.7%), foot
pain (29.1%), fibromyalgia (25.8%), migraine (19.7%),
arthritis (18.3%), neuropathic pain (17.8%), abdominal
pain (10.4%), myofascial pain (5.7%), chronic regional
pain syndrome (5.2%), chronic fatigue syndrome (3.9%),
tension headache (3.5%), dizziness (3.1%), and diabetes
(3.1%). In terms of medications at intake, 67.6% were prescribed an antidepressant and 61.9% were prescribed pain
medications.

Measures
MMPI‑2‑RF
The MMPI-2-RF is described in detail in the Introduction.
Psychometric properties of scores from the instrument
are reported by Tellegen and Ben-Porath (2008/2011).
Descriptive statistics and reliability estimates are provided
for the Validity Scales in Table 2, the Restructured Clinical Scales in Table 3, and the remaining substantive scales
in Table 3.
MMPI‑2
The MMPI-2 Clinical Scales were examined in this study
because the vast majority of MMPI chronic pain research
focuses on these scales (Tarescavage, 2015). The MMPI-2
Manual (Butcher et al., 2001) provides detailed information
on the psychometrics of Clinical Scale scores in a variety of
different samples. Of note, the Masculinity–Feminity and
Introversion Clinical Scales were not investigated because
they do not measure constructs relevant to psychopathology.
Reliability estimates of MMPI-2 Clinical Scale scores in the
current sample are provided in Table 3.

Table 2  MMPI-2-RF Validity Scale Scores (N = 230)
MMPI-2-RF scale name (abbreviation)
Inconsistent responding
Variable response inconsistency (VRIN-r)
True response inconsistency (TRIN-r)
Overreporting Scales
Infrequent responses (F-r)
Infrequent psychopathology responses (Fp-r)
Infrequent somatic responses (Fs)
Symptom validity (FBS-r)
Response bias (RBS)
Underreporting Scales
Uncommon virtues (L-r)
Adjustment validity (K-r)

α

M

SD

.17
.12

51.6
57.4

9.7
6.4

.70
.37
.58
.67
.68

69.2
52.6
64.8
71.2
66.4

15.5
10.8
18.2
13.2
15.8

.44
.65

53.4
46.7

9.3
9.4

MMPI-2-RF Minnesota Multiphasic Personality Inventory-2-Restructured Form, RC restructured clinical, M mean, SD standard deviation,
α Cronbach’s alpha

Depression, Anxiety, Stress Scales
The Depression, Anxiety, Stress Scales (DASS) (Lovibond
& Lovibond, 1996) is a 42-item self-report measure of mood
problems. It has three scales measuring depression, anxiety,
and generalized distress. Scores from the test have demonstrated adequate internal consistency reliability in a variety
of settings (Lovibond & Lovibond, 1996) and have documented sensitivity to change (Page, Hooke, & Morrison,
2007).
Pain Variables
Patients rated the severity of their pain at intake on 11-point
scales (0–10). The average pain intensity was 6.7 (SD = 2.0).
They also reported the duration of their pain, which ranged
from 1 to 63 years. The average duration of pain was
11.6 years (SD = 9.9).

Procedure
Upon admission to the Chronic Pain Rehabilitation Program (CPRP), all patients were given the MMPI-2 as part
of a battery of tests including self-reported measures, and
extensive patient and collateral interviews. The MMPI-2
was used, in part, to render psychological diagnoses, but
largely to guide treatment. Participants were not excluded
from treatment based on MMPI-2 scores. Evaluation dates
ranged from 1999 to 2008. The CPRP is a comprehensive,
intensive, interdisciplinary program that includes physical
therapy, occupational therapy, group and individual psychological therapy, and medication management, including the
weaning of all addicting substances including opioids and

Table 3  MMPI-2-RF RC Scales and MMPI-2 Clinical Scales descriptives and correlations with latent emotional distress outcome controlling for
intake emotional distress, gender, age, pain intensity, and pain duration
MMPI-2-RF Scale name (abbreviation)

α

M

SD

routcome

MMPI-2 Scale name (abbreviation)

α

M

SD

routcome

d

Restructured Clinical Scales
Demoralization (RCd)
Somatic complaints (RC1)
Low positive emotions (RC2)
Cynicism (RC3)
Antisocial behavior (RC4)
Ideas of persecution (RC6)
Dysfunctional negative emotions (RC7)
Aberrant experiences (RC8)
Hypomanic activation (RC9)

.89
.80
.70
.83
.73
.66
.85
.67
.77

62.4
71.1
62.3
48.2
51.5
53.5
54.1
53.8
46.0

11.0
11.4
11.5
10.4
10.0
11.2
11.6
10.2
9.1

.29***
.13
.13
.34***
.21**
.26***
.38***
.31***
.30***

Clinical Scales
–
Hypochondriasis (CS1)
Depression (CS2)
Hysteria (CS3)
Psychopathic deviate (CS4)
Paranoia (CS6)
Psychasthenia (CS7)
Schizophrenia (CS8)
Mania (CS9)

.80
.41
.65
.64
.43
.88
.88
.49

–
76.5
76.6
78.7
62.8
60.8
67.9
67.4
52.0

–
10.3
13.3
13.8
11.9
11.8
12.0
12.0
9.3

–
− .05
.04
− .10
.02
.13
.15
.20*
.04

–
.50
1.15
2.52a
1.03
.63
1.17
1.23
.65

Consistent with interpretive guidelines, Clinical Scales are K-corrected (Graham, 2012)
Italicized findings attained a statistically significant and clinically meaningful effect size (r ≥ .20)
MMPI-2-RF Minnesota Multiphasic Personality Inventory-2-Restructured Form, RC restructured clinical, M mean, SD standard deviation.
routcome correlation with outcome variable, d Cohen’s d comparing mean RC versus CS scores, α Cronbach’s alpha
a

RC3 measures one component of CS3, naivete, which is reversed to measure cynicism. Therefore, the RC3/CS3 comparisons reflect not only
differences in psychometric properties but also in direction of keying
*p < .05; **p < .01; ***p < .001

benzodiazepines as well as sedative hypnotics. Education
about addiction and chemical dependency was offered as
needed. The average length of stay is 3½ weeks and the
treatment day extends from 7:30 am–5 pm, 5 days a week.
Use of the sample was approved by an institutional review
board.

Analysis Plan
MMPI‑2 and MMPI‑2‑RF Mean Score Comparisons
We first examined mean score differences between the
MMPI-2 Clinical Scales and MMPI-2-RF RC Scales in
the sample. We compared the values using Cohen’s d, with
values of .30, .50, and .80 representing small, medium,
and large differences, respectively (Cohen, 1992). This
analysis was intended to build on research by McCord and
Drerup (2011) who found that the structural problems of
the MMPI-2 Clinical Scales limited their interpretive utility relative to the MMPI-2-RF RC Scales. These authors
categorized a sample of chronic pain patients into depressed
and nondepressed diagnostic groups. In the depressed group
in their study, mean clinical elevations were observed for the
following Clinical Scales: 1 (Hypochondriasis), 2 (Depression), 3 (Hysteria), 4 (Psychopathic Deviate), 6 (Paranoia),
7 (Psychastenia), and 8 (Schizophrenia). In stark contrast to
the Clinical Scale findings, mean RC scale elevations were
observed in the depressed group for only RCd (demoralization), RC1 (somatic complaints), and RC2 (low positive
emotions), demonstrating substantially improved discriminant validity and interpretive utility.

MMPI‑2 and MMPI‑2 RF Associations with Outcome
Associations between the MMPI-2 Clinical Scales and
MMPI-2-RF substantive scales, on the one hand, and treatment outcomes, on the other, were examined next in a structural equation modeling framework. All the analyses were
completed in Mplus. Version 6.11 (Muthén & Muthén, 2010)
using the Maximum Likelihood (ML) estimator. Model fit
was evaluated using the χ2 test, the Comparative Fit Index
(CFI) (Bentler, 1990), the Tucker Lewis Index (TLI) (Bentler
& Bonett, 1980), and the Root Mean Square of Approximation (RMSEA) (Steiger, 1998). Nonsignificant χ2 tests
(p > .05), CFI and TLI values greater than .90, and RMSEA
values less than .08 are indicative of adequate fit (Bentler,
1990; Browne, Cudeck, Bollen, & Long, 1993; Vandenberg
& Lance, 2000; Yu, 2002). However, because the χ2 test is
overpowered in larger samples like the current one, statistically significant findings do not necessarily indicate poor fit.
We first identified a measurement model for the outcome
variable, with scales from the DASS being used to model
latent emotional distress factors at intake and discharge. We
specified the intake factor as a predictor of the discharge factor to control for baseline emotional functioning (see Fig. 1
for final parameter estimates), a method recommended by
Little (2013). The indicators were approximately normally
distributed, supporting use of maximum likelihood estimation. The resulting model fit adequately. Specifically, the
χ2 test was nonsignificant (χ2[5] = 8.23, p = .14), and the
other fit indices were also adequate (CFI = .99; TLI = .99;
RMSEA = .05, 95% CI = .00 to .087). As reported later, we
next specified age, gender, pain intensity, and duration of

Fig. 1  Emotional distress
measurement model. All parameter estimates are statistically
significant (p < .013). Manifest
variables are scales from the
depression anxiety stress scales.
Residuals are in parentheses

Intake
Emotional Distress

.83
(.31)

Depression

.77
(.41)

Anxiety

Discharge
Emotional Distress

.24

.75
(.43)

.87
(.24)

Depression

Stress

.75
(.44)

Anxiety

.90
(.19)

Stress

.39
.44
.30

pain as predictors of discharge emotional distress to control
for these variables, a method also recommended by Little
(2013). To identify associations between the MMPI-2-RF
scales and future outcome, we correlated the test’s scales
with the outcome variable at discharge. Traditional MMPI
guidelines indicate that a correlation of .20 or greater is clinically meaningful (Graham, Ben-Porath, & McNulty, 1999).
Consistent with this guideline, we only interpreted statistically significant correlations (p < .05) yielding a magnitude
of .20 or greater.
MMPI‑2 and MMPI‑2 RF Associations with Recovery
Finally, we examined associations between MMPI-2 and
MMPI-2-RF scores and emotional distress outcome in the
context of the clinically significant change model of outcome measure progress developed by Jacobson and Truax
(Jacobson & Truax, 1991). According to this model and
in the context of this study, clinically significant recovery
occurs when a distressed individual achieves a statistically
significant and reliable change (i.e., 1.96 multiplied by the
outcome measure’s standard error of difference) that is more
characteristic of the general (nondistressed) population than
the patient (distressed) population. For the purposes of the
current study, individuals were deemed to have recovered if
their DASS total score decreased/improved by 9.03 points
(Reliable Change Index) to a score below 30.38 (midpoint
between nondistressed and distressed population).
The just mentioned values were derived from DASS
general population normative data provided by Crawford
and Henry (Crawford & Henry, 2003) as well as the intake
DASS scores in the current study using formula provided

by Jacobson and Truax (1991). Specifically, for the Reliable Change Index, the general population normative data
indicated a standard error of measurement of 3.26. Applying the following formula (Jacobson & Truax, 1991)
yielded a value of 9.03 for the Reliable Change Index:
1.96 × sqrt(2 × 3.262). For the midpoint between the nondistressed versus distressed samples, we utilized means and
standard deviations from the general population normative sample of DASS scores (M = 18.38, SD = 18.82) and
from the study sample of intake DASS Scores (M = 48.41,
SD = 28.28). The following formula (Jacobson & Truax,
1991) yielded a value of 30.38 for the midpoint of the nondistressed population versus distressed population: {[(28.2
8 × 18.38) + (18.82 × 48.41)]/(18.82 + 28.28)}.
DASS Total Scores were available at both the intake
and discharge time points for 181 members of the current
sample. Overall, 91 of these individuals (50.3%) met the
criterion for recovered, such that their DASS Total Score
decreased by more than 9.03 points (Reliable Change
Index) to a value less than 30.38 (nondistressed vs. distressed population midpoint). Of the 90 remaining individuals, 10 individuals (5.5%) had a change that was less
than the Reliable Change Index, 6 individuals (3.1%) had
a reliable change in the direction of deterioration, and 17
individuals (8.9%) had a reliable change in the direction
of improvement but ultimately did not have a score below
the nondistressed/distressed population midpoint of 30.38.
These 33 individuals (18.2%) were therefore considered to
have not recovered. The remaining 57 individuals (29.8%)
had DASS intake and discharge scores that were both in
the nondistressed range; therefore, they neither met criteria for recovered nor nonrecovered. We compared mean

MMPI-2 and MMPI-2-RF T-scores across the recovered
(n = 91) and nonrecovered (n = 33) groups using t-tests
and examined effect size using Cohen’s d. Consistent
with traditional MMPI guidelines (Graham, Ben-Porath, &
McNulty, 1999), we interpreted comparisons that yielded a
statistically significant (p < .05) and clinically meaningful
effect size (d ≥ .40, which is equivalent to r ≥ .20).

Results
MMPI‑2 and MMPI‑2‑RF Mean Score Comparisons
We present in Table 3 MMPI-2-RF RC Scale T-score
means and standard deviations for this sample alongside
MMPI-2 Clinical Scale T-score means and standard deviations. The sample produced clinically significant mean elevations (i.e., a score ≥ 65T) on only RC1 (Somatic Complaints). The sample scored at or above 60T (one standard
deviation above the general population mean) on RCd
(Demoralization) and RC2 (Low Positive Emotions). In
contrast, the sample produced clinically significant mean
elevations on most of the MMPI-2 Clinical Scales, including CS1 (Hypochondriasis), CS2 (Depression), CS3 (Hysteria), CS7 (Psychasthenia), and CS8 (Schizophrenia). The
CS4 (Psychopathic Deviate) and CS6 (Paranoia) scales
approached the threshold of a clinical elevation (both
T-score were greater than 60). Only CS9 (Mania) was
within one standard deviation of the general population
mean (i.e., a T-score less than 60T). In general, MMPI-2
Clinical Scale T-scores were substantially higher than RC
Scale T-scores, with Cohen’s d values ranging from .50
(RC1/CS1) to 2.52 (RC3/CS3). Of note, RC3 measures one
component of CS3, naivete, which is reversed to measure
cynicism. For the interested reader, descriptive statistics
for the remaining MMPI-2-RF scales examined in this
study are presented in Table 2.

Effects of Age, Gender, Pain Intensity, and Duration
of Pain on Outcomes
As detailed in the analysis plan, we used age, gender, pain
intensity, and duration of pain as predictors of emotional
distress outcomes in order to control for these variables. In
the emotional distress model, age was a significant predictor of outcome (Standardized coefficient = − .24, p = .004),
but the remaining predictors were nonsignificant, including gender (Standardized coefficient = − .05, p = .56), pain
intensity (Standardized coefficient = − .13, p = .11), and
duration of pain (Standardized coefficient = .04, p = .61).

MMPI‑2 and MMPI‑2 RF Associations with Outcome
We present in Table 3 correlations between the MMPI-2-RF
RC scales and MMPI-2 Clinical Scales and emotional distress treatment outcomes after controlling for baseline functioning in these areas, as well as age, gender, pain intensity,
and pain duration. Most of the RC Scales were significantly,
meaningfully associated with the criterion, with the following scales yielding correlates greater than .20: RCd (Demoralizatoin), RC3 (Cynicism), RC4 (Antisocial Behavior), RC6
(Persecutory Ideation), RC7 (Dysfunctional Negative Emotions), RC8 (Aberrant Experiences), and RC9 (Hypomanic
Activation). In contrast, only Clinical Scale 8 (Schizophrenia) was statistically and meaningfully associated with outcome. Regarding the rest of the MMPI-2-RF substantive
scales (see Table 4), all five substantive domains were represented as predictors of poor emotional distress outcomes,
including emotional dysfunction (EID, HLP, NFC, STW,
AXY, BRF, and NEGE-r), behavioral dysfunction (BXD,
AGG, ACT, and DISC-r), thought dysfunction (THD and
PSYC-r), interpersonal dysfunction (SHY and DSF), and
somatic/cognitive dysfunction (MLS and COG).

MMPI‑2 and MMPI‑2 RF Associations with Recovery
Finally, we present in Table 5 mean score differences for the
MMPI-2-RF RC Scales and MMPI-2 Clinical Scales across
groups of individuals who either recovered following treatment according to the DASS (n = 91) or those who did not
recover according to this measure (n = 33). Most of the RC
Scales were significantly and meaningfully different across
the groups, with the following scales yielding Cohen’s d
effect sizes greater than .40 (indicating higher-pretreatment
scores in the nonrecovered group): RCd (Demoralizatoin),
RC3 (Cynicism), RC4 (Antisocial Behavior), RC6 (Persecutory Ideation), RC7 (Dysfunctional Negative Emotions), RC8 (Aberrant Experiences), and RC9 (Hypomanic
Activation). In contrast, only Clinical Scale 9 (Mania) was
statistically and meaningfully higher in the nonrecovered
group of the two groups. Regarding the rest of the MMPI2-RF substantive scales (see Table 5), most of the substantive domains were significantly and meaningfully higher in
the nonrecovered group, including behavioral dysfunction
(JCP, SUB, AGG, DISC-r), thought dysfunction (PSYCr), interpersonal dysfunction (DSF), and somatic/cognitive
dysfunction (COG). Overall and in general terms, mean
T-scores in the nonrecovered group approximated a clinical
elevation (65T) on scales measuring emotional dysfunction
and somatic/cognitive complaints, whereas they typically
approximated a score of 55T for scales measuring behavioral
dysfunction in this same group. Thought dysfunction scores
in the nonrecovered group approximated a T-score of 60.

Table 4  MMPI-2-RF higherorder, specific problems, and
personality psychopathology-5
scale descriptives and
correlations with latent
emotional distress outcome
controlling for intake emotional
distress, gender, age, pain
intensity, and pain duration

MMPI-2-RF Scale name (abbreviation)
Higher-Order Scales
Emotional/internalizing dysfunction (EID)
Thought dysfunction (THD)
Behavioral/externalizing dysfunction (BXD)
Specific Problems Scales
Malaise (MLS)
Gastrointestinal complaints (GIC)
Head pain complaints (HPC)
Neurological complaints (NUC)
Cognitive complaints (COG)
Suicidal/death ideation (SUI)
Helplessness/hopelessness (HLP)
Self-doubt (SFD)
Inefficacy (NFC)
Stress/worry (STW)
Anxiety (AXY)
Anger proneness (ANP)
Behavior-restricting fears (BRF)
Multiple specific fears (MSF)
Juvenile conduct problems (JCP)
Substance abuse (SUB)
Aggression (AGG)
Activation (ACT)
Family problems (FML)
Interpersonal passivity (IPP)
Social avoidance (SAV)
Shyness (SHY)
Disaffiliativeness (DSF)
Personality-Psychopathology-5 Scales
Aggressiveness-revised (AGGR-r)
Psychoticism-revised (PSYC-r)
Disconstraint-revised (DISC-r)
Negative emotionality/neuroticism-revised (NEGE-r)
Introversion/low positive emotionality-revised (INTR-r)

α

M

SD

routcome

.90
.64
.77

62.2
53.0
48.6

11.6
9.9
9.8

.30***
.25***
.27***

.51
.71
.74
.66
.77
.67
.60
.75
.76
.60
.62
.76
.52
.70
.66
.63
.61
.59
.68
.70
.80
.77
.60

76.4
64.8
64.5
69.9
63.2
54.8
52.7
58.7
53.9
56.7
57.7
53.5
53.9
50.8
50.3
50.3
48.6
47.9
53.0
52.2
53.0
51.2
52.9

7.9
16.6
10.3
13.2
14.1
16.0
12.4
12.0
11.6
11.3
14.8
12.0
12.0
9.4
10.9
10.1
9.4
9.9
11.1
10.7
11.0
10.8
12.7

.21**
− .07
.10
.15
.39***
.04
.31***
.05
.29***
.30***
.26**
.20*
.25***
.09
.19*
.15
.22**
.26***
.17*
.01
.16*
.26***
.29***

.76
.62
.75
.81
.79

47.3
52.9
48.2
57.9
57.3

9.6
9.8
9.8
12.3
12.2

.03
.31***
.25**
.36***
.05

*p < .05; **p < .01; ***p < .001
Italicized findings attained a statistically significant and clinically meaningful effect size (r ≥ .20)
MMPI-2-RF Minnesota Multiphasic Personality Inventory-2-Restructured Form, RC restructured clinical,
M mean, SD standard deviation, routcome correlation with outcome variable, d Cohen’s d comparing mean
RC versus CS scores, α Cronbach’s alpha

Discussion
The purpose of this study was to examine the relative utility of the MMPI-2-RF substantive scales compared to the
MMPI-2 Clinical Scales in the prediction of emotional distress outcomes among patients with chronic low back pain
undergoing intensive outpatient treatment. Descriptive
analyses of MMPI-2-RF scores indicated that the current
sample reported relatively high levels of somatic problems, as well as mood disorder-related symptomatology.

However, in comparisons of the RC and MMPI-2 Clinical Scales, scores on the latter suggested substantially
more severity and variability in psychopathology. Finally,
scales from all domains from the MMPI-2-RF demonstrated associations with psychological distress outcome,
whereas MMPI-2 Clinical Scale scores generally did not
demonstrate meaningful associations. These results were
consistent with clinically relevant comparisons across
groups of individuals who at discharge either recovered
or did not recover from their intake level of psychological

Table 5  Mean comparisons
between emotional distress
recovered and not recovered
groups

Scale name (abbreviation)

MMPI-2-RF Higher-Order Scales
Emotional/internalizing dysfunction (EID)
Thought dysfunction (THD)
Behavioral/externalizing dysfunction (BXD)
MMPI-2-RF restructured Clinical Scales
Demoralization (RCd)
Somatic complaints (RC1)
Low positive emotions (RC2)
Cynicism (RC3)
Antisocial behavior (RC4)
Ideas of persecution (RC6)
Dysfunctional negative emotions (RC7)
Aberrant experiences (RC8)
Hypomanic activation (RC9)
MMPI-2 Clinical Scales
Hypochondriasis (CS1)
Depression (CS2)
Hysteria (CS3)
Psychopathic deviate (CS4)
Paranoia (CS6)
Psychasthenia (CS7)
Schizophrenia (CS8)
Mania (CS9)
MMPI-2-RF specific problems Scales
Malaise (MLS)
Gastrointestinal complaints (GIC)
Head pain complaints (HPC)
Neurological complaints (NUC)
Cognitive complaints (COG)
Suicidal/death ideation (SUI)
Helplessness/hopelessness (HLP)
Self-doubt (SFD)
Inefficacy (NFC)
Stress/worry (STW)
Anxiety (AXY)
Anger proneness (ANP)
Behavior-restricting fears (BRF)
Multiple specific fears (MSF)
Juvenile conduct problems (JCP)
Substance abuse (SUB)
Aggression (AGG)
Activation (ACT)
Family problems (FML)
Interpersonal passivity (IPP)
Social avoidance (SAV)
Shyness (SHY)
Disaffiliativeness (DSF)

Recovered Not
(n = 91)
recovered
(n = 33)

Statistical comparisons

M

t

SD

M

SD

64.1 11.1 67.8 11.0
53.6 10.2 57.1 9.4
46.5 8.1 56.7 12.0

Sig.

d

1.648 .102
.34
1.721 .088
.36
5.424 < .001 1.02

64.2
72.5
63.0
48.0
49.6
53.8
55.6
54.3
45.9

10.1
11.1
11.0
9.4
9.3
11.7
10.6
10.0
8.8

68.8
71.7
63.9
56.5
57.5
59.9
61.3
59.0
53.1

9.3
2.269 .025
.47
11.5 − 0.342 .733
− .07
13.4
0.386 .701
.07
14.0
3.871 < .001 .73
11.5
3.914 < .001 .76
11.6
2.596 .011
.53
12.0
2.533 .013
.50
10.1
2.312 .022
.47
11.6
3.652 < .001 .70

77.3
79.5
80.4
63.1
62.5
69.9
68.2
51.1

10.2
12.8
14.8
12.4
12.4
10.9
11.8
8.6

75.5
76.5
76.8
64.9
63.4
72.2
72.7
55.4

12.6 − 0.804 .423
13.1 − 1.152 .252
15.7 − 1.181 .240
11.1
0.726 .469
11.7
0.362 .718
11.4
1.036 .302
10.9
1.931 .056
9.6
2.410 .017

− .16
− .23
− .24
.15
.07
.21
.40
.48

76.8
66.4
65.5
71.0
63.6
56.4
52.6
60.5
55.4
58.2
58.7
55.2
54.9
51.6
49.0
47.8
48.4
49.0
53.5
50.5
52.9
51.8
53.4

7.6
16.5
10.3
12.9
13.0
17.4
11.3
11.8
11.2
10.0
14.2
11.7
12.1
10.4
10.6
8.0
8.5
9.8
12.1
9.3
11.1
10.9
12.7

79.0
64.4
64.5
71.3
70.9
56.9
57.5
61.1
58.2
60.7
64.8
59.3
58.3
49.6
56.4
56.9
54.8
50.9
55.7
52.3
56.3
55.6
60.2

7.6
1.447 .150
16.3 − 0.616 .539
9.1 − 0.502 .617
12.6
0.138 .890
12.2
2.820 .006
16.3
0.149 .882
14.7
1.956 .053
11.8
0.248 .805
10.1
1.252 .213
11.9
1.183 .239
17.4
1.971 .051
13.2
1.660 .100
12.6
1.377 .171
7.0 − 1.045 .298
12.2
3.307 .001
12.6
4.782 < .001
12.9
3.188 .002
10.9
0.936 .351
12.0
0.873 .384
11.6
0.871 .385
12.2
1.434 .154
11.7
1.692 .093
17.2
2.391 .018

.29
− .13
− .11
.03
.58
.03
.38
.05
.26
.23
.38
.33
.28
− .24
.65
.89
.60
.19
.18
.17
.28
.34
.46

Table 5  (continued)

Scale name (abbreviation)

MMPI-2-RF personality-psychopathology-5 Scales
Aggressiveness-revised (AGGR-r)
Psychoticism-revised (PSYC-r)
Disconstraint-revised (DISC-r)
Negative emotionality/neuroticism-revised (NEGE-r)
Introversion/low positive emotionality-revised (INTR-r)

Recovered Not
(n = 91)
recovered
(n = 33)

Statistical comparisons

M

t

SD

M

SD

48.1 9.5 49.8 11.9
0.833
53.3 10.2 57.6 8.7
2.147
45.4 7.4 56.1 11.7
6.014
59.9 11.8 64.1 11.9
1.734
58.0 12.9 57.6 13.1 − 0.154

Sig.

d

.406
.034
< .001
.085
.878

.16
.45
1.12
.35
− .03

Consistent with interpretive guidelines, Clinical Scales are K-corrected (Graham, 2012)
Italicized findings attained a statistically significant and clinically meaningful effect size (d ≥ .40)
MMPI-2-RF Minnesota Multiphasic Personality Inventory-2-Restructured Form, M mean, SD standard
deviation, d Cohen’s d

distress. Several aspects of these findings warrant further
discussion.
As just noted, mean comparisons of the RC and Clinical
Scales tended to demonstrate much higher scores across the
Clinical Scales. Moreover, the pattern of mean RC Scale
scores appeared more consistent with the types of psychopathology present in the sample. For example, approximately
half of the sample had a comorbid major depressive disorder,
which is consistent with the observed mean subthreshold
elevations of approximately 62T on RCd (demoralization)
and RC2 (low positive emotions). One would expect overall sample mean scores of 65T or higher only if the entire
sample had major depressive disorder, which is not the case.
Along the same lines, the observed mean elevation on RC1
(somatic complaints) is to be expected among a sample of
patients with chronic low back pain. In contrast, the Clinical
Scales demonstrated a substantially higher mean score on its
measure of depression (CS2); indeed, it was consistent with
the 99th percentile in the general population. Moreover, the
MMPI-2 Clinical Scales evidenced subthreshold to threshold mean elevations on scales that did not reflect psychopathology commonly found in this population (Psychopathic
Deviate, Paranoia, and Schizophrenia). Taken together and
in line with past research (McCord & Drerup, 2011), the
MMPI-2-RF RC Scales appeared to evidence more interpretive utility and particularly discriminant validity than did the
MMPI-2 Clinical Scales in this setting.
Correlation comparisons across the MMPI-2-RF and
MMPI-2 Scales more directly demonstrated the limitations of the Clinical Scales. Whereas 7 of the 9 RC Scales
(and several other MMPI-2-RF Scales) were significantly,
meaningfully associated with the outcome variable, only
one MMPI-2 Clinical Scale (Schizophrenia) demonstrated
a significant association. The latter finding is consistent
with most past research indicating that MMPI/MMPI-2
Scale scores are not associated with outcomes in this setting

(McGill, Lawlis, Selby, Mooney, & McCoy, 1983; Moore,
Armentrout, Parker, & Kivlahan, 1986). However, notwithstanding the limitations of its predecessors, the newest version of the MMPI—the MMPI-2-RF—was meaningfully
associated with outcomes in this study, likely owing to its
improved psychometrics and convergence with modern
models of psychopathology (Sellbom, Ben-Porath, & Bagby,
2008).
Findings from mean comparisons of recovered and not
recovered groups using a clinically significant change framework generally converged with the correlational results.
However, these findings have more direct clinical implications, as robust correlation coefficients do not necessarily
translate to actual treatment gains or losses as a result of
higher scores on a Scale. Moreover, the mean comparisons
across recovered and not recovered groups enable practitioners to identify which scores on a scale are most likely
to be associated with a problematic outcome. Accordingly,
the results indicated that practitioners should interpret
the MMPI-2-RF with some flexibility rather than strictly
adhere to interpretations of 65T or higher (for the purposes
of identifying individuals at risk for poor emotional distress
outcomes). For example, BXD demonstrated a large effect
size (Cohen’s d = 1.02) in differentiating recovered and not
recovered groups, with a mean score of 57T in the nonrecovered group.

Treatment Implications
The findings of this study can be used to assist with interpretation of the MMPI-2-RF in this setting, such that individuals with marked scores on scales associated with poor
outcome can be provided targeted interventions to increase
their chances of success. In order to inform treatment, a
brief description of how scales with the most robust findings
can impede treatment are described next, using the test’s
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interpretive manual as a guide (Ben-Porath & Tellegen,
2008/2011).
Although individuals presenting with higher scores on
the Emotional/internalizing scales (Emotional/internalizing dysfunction, dysfunctional negative emotions, helplessness/hopelessness, stress/worry, and negative emotionality/
neuroticism-revised) might be initially motivated to engage
in treatment due to their distress, they may disengage after
their distress levels begin to subside. Scores on scales that
assess negatively emotionality and its facets had the strongest associations with poorer emotional distress functioning
post-treatment, indicating the importance of targeting these
constructs in treatment planning. These findings converge
with those of Marek, Block, and Ben-Porath (2014), who
found that MMPI-2-RF markers of emotional distress,
depression, and negative emotionality were associated with
pain disability outcomes after spinal cord surgery.
Individuals with high scores on the Behavioral/externalizing dysfunction, hypomanic activation, and disconstraint scales are likely to be noncompliant with treatment
efforts due to excessive activation, antisocial orientation, or
impulsivity. Unusual thoughts and cognitions, as evidenced
by moderately elevated scores on scales such as Aberrant
Experiences and psychoticism-revised, may interfere with
treatment as well. Individuals with greater cynical and disaffiliative attitudes may have difficulty forming a therapeutic relationship, and they may have less access to socially
supportive others, which may account for the associations
between RC3 and DSF with poor outcomes. The RC3 findings are consistent with past research showing high scores
on this scale can lead poor treatment engagement among
national guard soldiers (Arbisi, Polusny, Erbes, Thuras, &
Reddy, 2011). Finally, patients with higher scores on cognitive complaints are likely to have a low tolerance for frustration, which could impede the benefits of participating in an
intensive chronic pain treatment program.
Although not a focus of the current study, it is worth mentioning that the MMPI-2-RF Validity Scales can also aid in
treatment efforts by assessing a patient’s response style. In
the current study, approximately 13% of patients from the
initial sample evidenced an invalid response style on the
MMPI-2-RF. That is, these individuals demonstrated inconsistent responding or overreporting of psychopathology or
somatic/cognitive complaints. Past research in other settings
has demonstrated that MMPI-2-RF identified overreporting
is likely to generalize to other aspects of the assessment
(Forbey, Lee, Ben-Porath, Arbisi, & Gartland, 2013). Thus,
in situations where an individual produces an invalid protocol, practitioners should be aware of the limitations of concurrently obtained patient data. Invalid protocols may also
have implications for treatment, as demonstrated by studies
in mental health settings (Anestis, Finn, Gottfried, Arbisi,
& Joiner, 2014). However, future research on the utility of

the MMPI-2-RF Validity Scales for this purpose in chronic
pain treatment is needed.

Limitations and Conclusion
Limitations of the current study provide direction for future
research. The sample was entirely composed of low back
pain patients. Although low back pain is the most common
complaint of individuals in this setting, it would be useful to see whether these findings generalize to other diagnoses, such as fibromyalgia, chronic fatigue syndrome,
migraine headaches, multiple sclerosis, and other neurological disorders. Moreover, replication of these results in
other types of chronic pain treatment settings is necessary,
as the patients in the current study participated in a structured interdisciplinary pain treatment program that was very
intensive. Although such a program is recommended, it does
not represent the treatment received by most pain patients.
Additionally, given the intensive nature of the program, the
severity of chronic pain and comorbid diagnoses such as
prescription opioid abuse may be greater than what is typically observed in outpatient settings. The results of the study
were analyzed in the context of exploration (Reichenbach,
1938), given the limited available research on the MMPI2-RF and chronic pain treatment outcomes. Consequently,
replication is needed. Moreover, the current study utilized
only one outcome measure—future research with multiple
and varied methods of outcomes assessment are indicated.
Along the same lines, some patient characteristics were not
assessed but could be relevant to the generalizability of the
study (e.g., treatment satisfaction). Finally, investigating
associations of MMPI-2-RF scores with other indicators of
outcome would be beneficial and may provide additional
insight into the utility of the instrument in assessments of
patients with chronic low back pain. For example, the Externalizing Scales may be useful in the prediction of treatment
nonadherence.
These limitations notwithstanding, the current study
is the first to investigate the utility of the MMPI-2-RF in
the prediction of treatment outcomes among chronic pain
patients undergoing conservative treatments. Overall, the
results of this study provide preliminary support for the use
of the MMPI-2-RF among patients with chronic low back
pain and should ease long-standing concerns that an MMPI
instrument is not useful in this setting.
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